Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New ER asthma shot aims to cut repeat attacks and steroid use

NCT ID NCT06705764

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 29 times

Summary

This study tests whether starting Tezepelumab, a monthly injection, in the emergency room can help adults with severe asthma recover faster and prevent future attacks that require another ER visit or steroid pills. About 100 adults aged 18-55 who have severe asthma and are on high-dose inhalers will receive either Tezepelumab or a placebo alongside standard care. The main goal is to see if the drug reduces moderate and severe asthma flare-ups within 90 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sturgeon Community Hospital

    St. Albert, Alberta, T8N6C4, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Alberta

    Edmonton, Ca-ab, T6G 2G3, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.